Latest news
Glasgow-based Mironid raises €39.9 million in Series B to advance rare kidney disease treatment - EU-StartupsEU-Startups · Fri, 07 Aug 2026 12:14:34 GMTProtein Intake and Kidney Function: No Link Found - MedscapeMedscape · Thu, 06 Aug 2026 09:24:34 GMTMironid banks $46m in Series B to take rare kidney disease drug closer to clinic - Pharmaceutical TechnologyPharmaceutical Technology · Wed, 05 Aug 2026 11:02:58 GMTMironid raises $46M to push rare kidney disease drug into the clinic - DealroomDealroom · Wed, 05 Aug 2026 08:58:56 GMTRoche-backed Mironid gets $46M boost to put rare kidney disease drug on path to clinic - FirstWord PharmaFirstWord Pharma · Wed, 05 Aug 2026 08:06:57 GMT